Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma

Figure 2 Kaplan-Meier plots and log rank test results. Disease-free survival (DFS) and overall survival (OS) in patients with resected esophageal squamous cell carcinoma (ESCC); A and B: According to FGFR1 amplification; C and D: According to MYC expression status; OS was also plotted according to FGFR1 amplification and MYC expression statuses; E and F: In patients with ESCC who did not receive adjuvant therapy; G and H: in those with ESCC who received adjuvant therapy; I-K: OS of patients with ESCC according to combined FGFR1 amplification and MYC expression status was plotted and analyzed in all patients with resected ESCC, as well as in those with and without adjuvant therapy, respectively. FGFR1: Fibroblast growth factor receptor 1.